2548 results found
Evaluation and reporting are essential for continuous quality improvement and so are embedded in the day-to-day work of NHMRC.
In 2021, NHMRC undertook a targeted consultation on NHMRC’s assessment of publications. Based on the results of this consultation, NHMRC began implementing a new policy relating to the assessment of publications for its track record-based schemes.The new policy limited applicants to list no more than 10 of their top publications in the past 10 years. The Top 10 in 10 publications policy evaluation report – which may be downloaded at the bottom of this page – describes the results of a process evaluation that sought to determine whether the policy has been implemented as intended.
Professor Angela Morgan is head of speech and language at the Murdoch Children’s Research Institute and Professor of Speech Pathology at the University of Melbourne and was the recipient of the 2020 NHMRC Elizabeth Blackburn Investigator Grant Award (Leadership in Clinical Medicine and Science).
Pioneering health consumer advocate Anne McKenzie AM has been awarded NHMRC’s Consumer Engagement Award in recognition of an almost 30-year career during which she has helped thousands of Australian clinicians and researchers understand the value of listening to consumers.
Professor Frédéric (Fred) Hollande is Deputy Head at the Department of Clinical Pathology, University of Melbourne, and a group leader at the University of Melbourne Centre for Cancer Research. He’s also behind the image recognised in the Science to Art NHMRC Biennial Award.
2021 ANSTO Eureka Prize for Innovative Use of Technology
The Human Frontier Science Program (HFSP) was established in 1990 to promote international collaboration in basic research focused on the elucidation of the sophisticated and complex mechanisms of living organisms. Since then, 1180 research grants have been awarded to more than 7500 researchers representing 71 nationalities, including Australia. HFSP Secretary-General Professor Pavel Kabat introduces the program and three prominent researchers tell us how their HFSP grants advanced their research.
Over the last 10 years NHMRC has invested more than $191 million in research on malaria1
An estimated 1 in 10 Australian adults (10%) - about 1.7 million people in 2011 - 12 - had biomedical signs of chronic kidney disease1
Glaucoma is a leading cause of irreversible blindness worldwide, with an estimated 80 million people predicted to be affected by 2020.
Hepatitis B is an infectious disease that causes the liver to become inflamed and contributes to increasing rates of liver cancer in Australia and globally.
Professor Louisa Jorm is the Foundation Director of the Centre for Big Data Research in Health at UNSW Sydney.